Coles N Anthony insider trades
Coles N Anthony has filed 33 Form 4s with the SEC that we hold, for CERE (Director) and Regeneron Pharmaceuticals, INC. (REGN) (Director). Across all of them we count 0 purchases worth $0 and 61 sales worth $51.0M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 5,100 shares of Regeneron Pharmaceuticals, INC. worth $3.3M, dated 2021-08-18. The first filing on our record is dated 2021-08-16 and the latest 2026-01-06.
CERE
Director · 23 filings · 28 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-09 | S, sale reported on Form 4 | 44,855 | $1.2M | 2022-12-13 |
| 2022-12-09 | S, sale reported on Form 4 | 5,145 | $139.4K | 2022-12-13 |
| 2023-01-05 | S, sale reported on Form 4 | 49,500 | $1.5M | 2023-01-06 |
| 2023-01-05 | S, sale reported on Form 4 | 500 | $15.4K | 2023-01-06 |
| 2023-02-07 | S, sale reported on Form 4 | 42,058 | $1.4M | 2023-02-08 |
| 2023-02-07 | S, sale reported on Form 4 | 7,942 | $266.6K | 2023-02-08 |
| 2023-03-02 | S, sale reported on Form 4 | 47,000 | $1.3M | 2023-03-06 |
| 2023-03-03 | S, sale reported on Form 4 | 3,000 | $81.6K | 2023-03-06 |
| 2023-04-11 | S, sale reported on Form 4 | 50,000 | $1.3M | 2023-04-13 |
| 2023-05-04 | S, sale reported on Form 4 | 37,568 | $1.2M | 2023-05-08 |
| 2023-05-04 | S, sale reported on Form 4 | 12,132 | $385.3K | 2023-05-08 |
| 2023-05-04 | S, sale reported on Form 4 | 300 | $9.9K | 2023-05-08 |
| 2023-06-01 | S, sale reported on Form 4 | 50,000 | $1.6M | 2023-06-05 |
| 2023-07-11 | S, sale reported on Form 4 | 50,000 | $1.5M | 2023-07-13 |
| 2023-09-07 | S, sale reported on Form 4 | 50,000 | $1.2M | 2023-09-08 |
| 2023-11-02 | S, sale reported on Form 4 | 38,599 | $972.3K | 2023-11-06 |
| 2023-11-03 | S, sale reported on Form 4 | 61,401 | $1.6M | 2023-11-06 |
| 2023-11-07 | S, sale reported on Form 4 | 27,076 | $677.4K | 2023-11-09 |
| 2023-11-08 | S, sale reported on Form 4 | 100 | $2.5K | 2023-11-09 |
| 2023-11-14 | S, sale reported on Form 4 | 22,824 | $573.6K | 2023-11-16 |
| 2024-01-02 | S, sale reported on Form 4 | 50,000 | $2.1M | 2024-01-04 |
| 2024-02-07 | S, sale reported on Form 4 | 2,506 | $104.1K | 2024-02-08 |
| 2024-02-29 | S, sale reported on Form 4 | 50,000 | $2.1M | 2024-03-04 |
| 2024-03-04 | S, sale reported on Form 4 | 50,000 | $2.1M | 2024-03-06 |
| 2024-04-01 | S, sale reported on Form 4 | 50,000 | $2.1M | 2024-04-03 |
| 2024-05-10 | S, sale reported on Form 4 | 50,000 | $2.1M | 2024-05-14 |
| 2024-06-03 | S, sale reported on Form 4 | 50,000 | $2.0M | 2024-06-05 |
| 2024-07-01 | S, sale reported on Form 4 | 25,000 | $1.0M | 2024-07-03 |
Regeneron Pharmaceuticals, INC. (REGN)
Director · 10 filings · 33 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-13 | S, sale reported on Form 4 | 2,000 | $1.2M | 2021-08-16 |
| 2021-08-17 | S, sale reported on Form 4 | 900 | $585.0K | 2021-08-19 |
| 2021-08-18 | S, sale reported on Form 4 | 5,100 | $3.3M | 2021-08-19 |
| 2021-09-15 | S, sale reported on Form 4 | 1,174 | $779.9K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 905 | $600.7K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 300 | $195.4K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 1,101 | $718.9K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 800 | $522.6K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 403 | $264.0K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 1,400 | $919.1K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 835 | $549.0K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 935 | $615.8K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 300 | $197.7K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 448 | $296.0K | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 3,344 | $2.2M | 2021-09-17 |
| 2021-09-15 | S, sale reported on Form 4 | 3 | $2.0K | 2021-09-17 |
| 2022-09-06 | S, sale reported on Form 4 | 602 | $351.9K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 822 | $477.9K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 1,045 | $609.4K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 1,220 | $710.7K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 688 | $399.3K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 300 | $173.0K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 500 | $288.5K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 273 | $157.9K | 2022-09-08 |
| 2022-09-06 | S, sale reported on Form 4 | 550 | $318.9K | 2022-09-08 |
| 2022-12-28 | S, sale reported on Form 4 | 181 | $128.1K | 2022-12-30 |
| 2022-12-28 | S, sale reported on Form 4 | 311 | $222.7K | 2022-12-30 |
| 2022-12-28 | S, sale reported on Form 4 | 1 | $710 | 2022-12-30 |
| 2022-12-28 | S, sale reported on Form 4 | 679 | $482.5K | 2022-12-30 |
| 2022-12-28 | S, sale reported on Form 4 | 100 | $71.2K | 2022-12-30 |
| 2022-12-28 | S, sale reported on Form 4 | 1,198 | $855.0K | 2022-12-30 |
| 2022-12-28 | S, sale reported on Form 4 | 1,022 | $730.3K | 2022-12-30 |
| 2022-12-28 | S, sale reported on Form 4 | 2,266 | $1.6M | 2022-12-30 |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1197018) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms